GPBAR1 and metabolic dysfunction-associated steatohepatitis: Next to bile acid receptors, the joint activation of TGR5 and other nuclear receptors such as peroxisome proliferator-activated receptors (PPARs) or liver X receptors (LXRs) would be of interest for the treatment of NASH [46].